Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Ovintiv Inc. (DE) (OVV) vs uniQure N.V. Ordinary Shares (QURE) Price & Performance

Ovintiv Inc. (DE)Trade
uniQure N.V. Ordinary SharesTrade

Price performance (Past 24H)

Key statistics

Ovintiv Inc. (DE) vs uniQure N.V. Ordinary Shares — how do they compare? Ovintiv Inc. (DE) trades at $66.75 (market cap $18.44B), while uniQure N.V. Ordinary Shares trades at $20.78 (market cap $1.48B). The key difference: Ovintiv Inc. (DE) is far larger — about 12.5× uniQure N.V. Ordinary Shares's market cap, and Ovintiv Inc. (DE) pays a 1.8% dividend while uniQure N.V. Ordinary Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Ovintiv Inc. (DE) for 6 Days and uniQure N.V. Ordinary Shares for 0 Days on average.

OVVQURE
Market Cap
$18.44B$1.48B
Volume
3,495,7252,488,780
Sector
EnergyHealth
52-Week High
$66.97$70.59
52-Week Low
$35.97$9.03
Typical Hold Time
6 Days0 Days
Enterprise Value
$22.77B$728.62M
Dividend Yield
1.8%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Ovintiv Inc. (DE)

OVV trades at $66.66, up 2.36% today, with a bullish technical outlook supported by moving averages and strong analyst consensus. The company reported mixed Q2 2026 earnings, missing EPS estimates but showing robust revenue growth. Recent news highlights expansion in Permian and Montney assets, share buybacks, and strong free cash flow generation, positioning the stock for potential upside.

The outlook for OVV is positive, driven by operational strength and strategic acquisitions, though risks include commodity price volatility and natural gas headwinds. With a consensus price target of $76.00 and no sell ratings, Wall Street sentiment remains bullish, offering a favorable risk-reward profile for investors seeking energy exposure.

uniQure N.V. Ordinary Shares

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

OVV

No sentiment data available yet.

QURE
100% Buy0% Sell
Avg holding period · 0 Days

About Ovintiv Inc. (DE)

Ovintiv explores for and produces oil and natural gas in North America. Its operations are concentrated in major U.S. and Canadian resource basins.

Read more on OVV →

About uniQure N.V. Ordinary Shares

uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.

Read more on QURE →